Segall Bryant & Hamill’s HNI HNI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$864K Buy
19,069
+296
+2% +$13.5K 0.01% 544
2026
Q2
$759K Sell
18,773
-14,555
-44% -$495K 0.01% 558
2026
Q1
$1.11M Buy
33,328
+871
+3% +$38.6K 0.02% 499
2025
Q4
$1.36M Sell
32,457
-93
-0.3% -$3.93K 0.02% 478
2025
Q3
$1.52M Buy
+32,550
New +$1.54M 0.02% 464
2024
Q4
– Sell
-13,987
Closed -$753K – 604
2024
Q3
$753K Buy
13,987
+287
+2% +$14.6K 0.01% 528
2024
Q2
$617K Buy
+13,700
New +$605K 0.01% 399

Other funds holding HNI

Segall Bryant & Hamill's HNI Position: Q3 2026 in Review

Segall Bryant & Hamill increased its HNI (HNI) stake by 1.6% in Q3 2026, buying an estimated $13.5K and bringing the position to 19,069 shares worth $864K. The position accounts for 0.01% of the portfolio, ranked #544.

Segall Bryant & Hamill first reported a position in HNI in Q2 2024 and has held it in 7 quarters since. The position peaked at $1.52M in Q3 2025. 302 funds tracked by Wall St. Rank hold HNI as of Q3 2026.

  • Segall Bryant & Hamill held 19,069 shares of HNI worth $864K as of Q3 2026.
  • Segall Bryant & Hamill bought 296 HNI shares in Q3 2026, an estimated $13.5K.
  • HNI made up 0.01% of Segall Bryant & Hamill's portfolio in Q3 2026, its #544 holding.
  • Segall Bryant & Hamill first reported a position in HNI in Q2 2024 and has held it in 7 quarters since.
  • Segall Bryant & Hamill's HNI position peaked at $1.52M in Q3 2025.
  • 302 funds tracked by Wall St. Rank held HNI as of Q3 2026.

Based on Segall Bryant & Hamill's 13F filing for Q3 2026, filed 16 Nov 2026.